Value of 18F-FDG PET/CT dual-phase imaging in preoperative diagnosis of axillary lymph node metastasis in patients with stage IIIA (N2) breast cancer

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900028144

Enrollment

Unknown

Registered

2019-12-13

Start date

2020-01-01

Completion date

Unknown

Last updated

2019-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Gold Standard:hematological test

Index test:18F-FDG PET/CT

Eligibility

Sex/Gender

All

Age

33 Years to 72 Years

Inclusion criteria

Inclusion criteria: All breast cancer patients had unilateral lesions; PET/CT dual-phase imaging 1-2 weeks before surgery.

Exclusion criteria

Exclusion criteria: Distant metastases; Combined with second primary tumor; Tumor-related treatment has been performed; Pregnancy or lactation.

Design outcomes

Primary

Measure	Time frame
SUVmax;SEN, SPE, ACC, AUC of ROC;	—

Countries

China

Contacts

Public ContactShengming Deng

The First Affiliated Hospital of Soochow University

dshming@163.com+86 18506291758

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026